Literature DB >> 16135576

Extended regimens of the contraceptive vaginal ring: a randomized trial.

Leslie Miller1, Carole H J Verhoeven, Johanna in't Hout.   

Abstract

OBJECTIVE: To compare the bleeding patterns and tolerability of 3 different extended ring regimens with those of the standard 28-day cycle with 21 days of contraceptive vaginal ring use followed by 7 ring-free days.
METHODS: Following a run-in 28-day ring cycle, women were randomized to 1 of 4 regimens: monthly (28-day cycle), every other month (49-day cycle), every third month (91-day cycle), or continuous (364-day cycle). Treatment duration was 1 year. Daily bleeding diary, interval visit questionnaire, and examination data were collected.
RESULTS: A total of 561 women were enrolled, 429 were subsequently randomized, and 289 (67.4%) women completed the entire year. All schedules were well tolerated and acceptable to women, but study completion rates were higher for the shorter cycles. Bleeding days were reduced with postponement of the withdrawal bleeding (ring-free) week, but spotting days increased. For example, women using the continuous or 364-day ring cycle reported a median of zero bleeding days but 10-12 days of spotting during the first 3 months of extended use. Unscheduled bleeding during ring use was the lowest with the traditional 28-day cycle. Adverse events, blood pressure, body weight, and laboratory findings were comparable over the 4 treatment groups.
CONCLUSION: The combination vaginal contraceptive ring can be used for extended cycles to alter the bleeding schedule. Women willing to tolerate some spotting might choose the longer extensions to have fewer menstrual periods. LEVEL OF EVIDENCE: I.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16135576     DOI: 10.1097/01.AOG.0000175144.08035.74

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  16 in total

1.  Cervical cancer treatment with a locally insertable controlled release delivery system.

Authors:  Vandana Keskar; Prem S Mohanty; Ernest J Gemeinhart; Richard A Gemeinhart
Journal:  J Control Release       Date:  2006-08-26       Impact factor: 9.776

2.  When to suggest this OC alternative.

Authors:  Kate Rowland; Sarah-Anne Schumann
Journal:  J Fam Pract       Date:  2009-04       Impact factor: 0.493

Review 3.  Contraception in Canada: a review of method choices, characteristics, adherence and approaches to counselling.

Authors:  William A Fisher; Amanda Black
Journal:  CMAJ       Date:  2007-03-27       Impact factor: 8.262

4.  Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world.

Authors:  Kathleen Ridgeway; Elizabeth T Montgomery; Kevin Smith; Kristine Torjesen; Ariane van der Straten; Sharon L Achilles; Jennifer B Griffin
Journal:  Contraception       Date:  2021-10-10       Impact factor: 3.051

5.  Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (NuvaRing).

Authors:  Devorah R Wieder; Lynn Pattimakiel
Journal:  Int J Womens Health       Date:  2010-11-12

6.  Contraceptive vaginal ring effectiveness is maintained during 6 weeks of use: a prospective study of normal BMI and obese women.

Authors:  Monica Dragoman; Kelsey Petrie; Anupama Torgal; Tiffany Thomas; Serge Cremers; Carolyn L Westhoff
Journal:  Contraception       Date:  2012-12-10       Impact factor: 3.375

Review 7.  Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception.

Authors:  Alison Edelman; Elizabeth Micks; Maria F Gallo; Jeffrey T Jensen; David A Grimes
Journal:  Cochrane Database Syst Rev       Date:  2014-07-29

8.  Adolescent and young women's experience with the vaginal ring and oral contraceptive pills.

Authors:  Felicia H Stewart; Beth A Brown; Tina R Raine; Tracy A Weitz; Cynthia C Harper
Journal:  J Pediatr Adolesc Gynecol       Date:  2007-12       Impact factor: 1.814

9.  Review of the combined contraceptive vaginal ring, NuvaRing.

Authors:  Frans Jme Roumen
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

Review 10.  Menstrual suppression: current perspectives.

Authors:  Paula Adams Hillard
Journal:  Int J Womens Health       Date:  2014-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.